Recombinant human follicle-stimulating hormone alters maternal ovarian hormone concentrations and the uterus and perturbs fetal development in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 4, 2006, Pages

  Kelley, Rebecca L ^a   Kind, Karen L ^a   Lane, Michelle ^a   Robker, Rebecca L ^a   Thompson, Jeremy G ^a   Edwards, Lisa J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Endometrium; Equine chorionic gonadotropin; Gonadotropin; Mouse; Ovarian stimulation

Indexed keywords

CHORIONIC GONADOTROPIN; DNA BINDING PROTEIN; ESTROGEN RECEPTOR; FOLLITROPIN; HORMONE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; RECOMBINANT PROTEIN; STEROID HORMONE; TRANSCRIPTION FACTOR HOXA10; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; EMBRYO TRANSFER; FEMALE; FETUS DEVELOPMENT; GENE EXPRESSION; GENE MUTATION; HOMEOBOX; MOUSE; NONHUMAN; OVULATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSEUDOPREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS;

ANIMALS; CHORIONIC GONADOTROPIN; CROSSES, GENETIC; EMBRYO IMPLANTATION; ENDOMETRIUM; ESTRADIOL; FEMALE; FETAL DEVELOPMENT; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; OVARY; OVULATION; PREGNANCY; PROGESTERONE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33749246859     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00079.2006     Document Type: Article

References (58)

1. Armstrong DT and Opavsky MA. Superovulation of immature rats by continuous infusion of follicle-stimulating hormone. Biol Reprod 39: 511-518, 1988.
2. Barnes FL. The effects of the early uterine environment on the subsequent development of embryo and fetus. Theriogenology 53: 649-658, 2000.
3. Bartholomeusz RK, Bruce NW, and Lynch AM. Embryo survival, and fetal and placental growth following elevation of maternal estradiol blood concentrations in the rat. Biol Reprod 61: 46-50, 1999.
4. Bhatt H, Brunet LJ, and Stewart CL. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci USA 88: 11408-11412, 1991.
5. Biggers JD and McGinnis LK. Evidence that glucose is not always an inhibitor of mouse preimplantation development in vitro. Hum Reprod 16: 153-163, 2001.
6. Bourgain C and Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update 9: 515-522, 2003.
7. Cai LQ, Cao YJ, and Duan EK. Effects of leukemia inhibitory factor on embryo implantation in the mouse. Cytokine 12: 1676-1682, 2000.
8. Carson DD, Bagchi I, Dey SK, Enders AC, Fazleabas AT, Lessey BA, and Yoshinaga K. Embryo implantation. Dev Biol 217-237, 2000.
9. Check JH. The use of the donor oocyte program to evaluate embryo implantation. Ann NY Acad Sci 734: 198-207, 1994.
10. Chen JR, Cheng J, Shatzer T, Sewell L, Harnandez L, and Stewart CL. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 141: 4365-4372, 2000.
11. Collins J. A turbulent arena. Fertil Steril 80: 1117-1120, 2003.
12. Conneely OM, Mulac-Jericevic B, DeMayo FJ, Lydon JP, and O'Malley BW. Reproductive functions of progesterone receptors. Recent Prog Horm Res 57: 339-355, 2002.
13. Devroey P, Bourgain C, Macklon NS, and Fauser BCJM. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab 15: 84-90, 2004.
14. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, and Wang H. Molecular cues to implantation. Endocr Rev 25: 341-373, 2004.
15. Edwards LJ, Kind KL, Armstrong DT, and Thompson JG. Effects of recombinant human follicle-stimulating hormone on embryo development in mice. Am J Physiol Endocrinol Metab 288: E845-E851, 2005.
16. Elmazar MMA, Vogel R, and Spielmann H. Maternal factors influencing development of embryos from mice superovulated with gonadotropins. Reprod Toxicol 3: 135-138, 1989.
17. Ertzeid G and Storeng R. Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice. J Reprod Fertil 96: 649-655, 1992.
18. Ertzeid G and Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod 16: 221-225, 2001.
19. Fanchin R, de Ziegler D, Taieb J, Hazout A, and Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 59: 1090-1094, 1993.
20. Forman R, Eychenne B, Nessmann C, Frydman R, and Robel P. Assessing the early luteal phase in in vitro fertilization cycles: relationships between plasma steroids, endometrial receptors, and endometrial histology. Fertil Steril 51: 310-316, 1989.
21. Fossum GT, Davidson A, and Paulson RJ. Ovarian hyperstimulation inhibits embryo implantation in the mouse. J In Vitro Fert Embryo Transf 6: 7-10, 1989.
22. Gidley-Baird AA, O'Neill CC, Sinosich MJ, Porter RN, Pike IL, and Saunders DM. Failure of implantation in human in vitro fertilization and embryo transfer patients: the effects of altered progesterone/estrogen ratios in humans and mice. Fertil Steril 45: 69-74, 1986.
23. Hadi FH, Chantler E, Anderson E, Nicholson R, McClelland RA, and Seif MW. Ovulation induction and endometrial steroid receptors. Hum Reprod 9: 2405-2410, 1994.
24. 164 in vascular permeability and angiogenesis during implantation. Genesis 26: 213-224, 2000.
25. Keene JL, Matzuk MM, Otani T, Fauser BC, Galway AB, Hseuh AJ, and Boime I. Expression of biologically active human follitropin in Chinese hamster ovary cells. J Biol Chem 264: 4769-4775, 1989.
26. Kleeman DO, Walker SK, and Seamark RF. Enhanced fetal growth in sheep administered progesterone during the first three days of pregnancy. J Reprod Fertil 102: 411-417, 1994.
27. Kolibianakis E, Bourgain C, Albano C, Osmanagoglu K, Smitz J, Van Steirteghem A, and Devroey P. Effect of ovarian stimulation with recombinant follicle stimulating hormone, gonadotropin releasing hormone agonists, and human chorionic gonadotrophin on endometrial maturation on the day of oocyte pick-up. Fertil Steril 78: 1025-1029, 2002.
28. Kramer B, Stein BA, and Van der Walt LA. Exogenous gonadotrophins - serum estrogen and progesterone and the effect on endometrial morphology. J Anat 173: 177-186, 1990.
29. Krushe CA, Herrier A, Classen-Linke I, Hegele-Hartung C, von Rango U, and Beier HM. Modulation of endometrial transformation in gonadotrophin-stimulated and unstimulated pseudo-pregnant rabbits: studies with the progesterone receptor antagonist, onapristone. Mol Hum Reprod 6: 726-734, 2000.
30. Lane M and Gardner DK. Increase in postimplantation development of cultured mouse embryos by amino acids and induction of fetal retardation and exencephaly by ammonium ions. J Reprod Fertil 102: 305-312, 1994.
31. Miller BG and Armstrong DT. Effects of a superovulatory dose of pregnant mare serum gonadotropin on ovarian function, serum estradiol, and progesterone levels and early embryo development in immature rats. Biol Reprod 25: 261-271, 1981.
32. Miller BG and Armstrong DT. Infertility in superovulated immature rats: role of ovarian steroid hypersecretion. Biol Reprod 26: 861-868, 1982.
33. Mirkin S, Nikas G, Hsiu JG, Diaz J, and Oehninger S. Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles. J Clin Endocrinol Metab 89: 5742-5752, 2004.
34. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, and Aragona C. A controlled trial of natural cycle versus microdose gonadotrophin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 81: 1542-1547, 2004.
35. Murphy BD, Mapleloft RJ, Manns J, and Humphrey WD. Variability in gonadotrophin preparations as a factor in the superovulatory response. Theriogenology 21, 1984.
36. Noci I, Borri P, Coccia ME, Criscuoli L, Scarselli G, Messeri G, Paglierani M, Moncini D, and Taddei G. Hormonal patterns, steroid receptors and morphological pictures of endometrium in hyperstimulated IVF cycles. Eur J Obstet Gynecol Reprod Biol 75: 215-220, 1997.
37. Rao C and Lei Z. Consequences of targeted inactivation of LH receptors. Mol Cell Endocrinol 187: 57-67, 2002.
38. Saadat P, Boostanfar R, Slater CC, Tourgeman DE, Stanczyk FZ, and Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril 82: 167-171, 2004.
39. Safro E, O'Neill C, and Saunders DM. Elevated luteal phase estradiol: progesterone ratio in mice causes implantation failure by creating a uterine environment that suppresses embryonic metabolism. Fertil Steril 54: 1150-1153, 1990.
40. Salehnia M. Different pattern of pinopodes expression in stimulated mouse endometrium. Exp Anim 54: 349-352, 2005.
41. Satokata I, Benson G, and Maas R. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 374: 460-463, 1995.
42. Schoolcraft WB, Sinton E, Schlenker T, Huynh D, Hamilton F, and Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 55: 563-566, 1991.
43. Shemesh M. Actions of gonadotrophins on the uterus. Reproduction 121: 835-842, 2001.
44. Shen MM and Leder P. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci USA 89: 8240-8244, 1992.
45. 43a. Short DJ. The IAT Manual of Laboratory Animal Practice and Technique (2nd ed.). London, UK: Crosby Lockwood & Son, 1969, p. 342.
46. Sibug RM, de Koning J, Tijssen AM, de Ruiter MC, de Kloet ER, and Helmerhorst FM. Urinary gonadotrophins but not recombinant gonadotrophins reduce expression of VEGF120 and its receptors flt-1 and flk-1 in the mouse uterus during the peri-implantation period. Hum Reprod 20: 649-656, 2005.
47. Sibug RM, Helmerhost FM, Tijssen AMI, de Kloet ER, and de Koning J. Gonadotrophin stimulation reduces VEGF120 expression in the mouse uterus during the peri-implantation period. Hum Reprod 17: 1643-1648, 2002.
48. Simon C, Garcia Velasco JJ, Valbuena D, Peinado JA, Moreno C, Remohi J, and Pellicer A. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril 70: 234-239, 1998.
49. 2α deficiency SK is crucial for 'on-time' embryo implantation that directs subsequent development. Development 129: 2879-2889, 2002.
50. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, and Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359: 76-79, 1992.
51. Tan J, Paria BC, Dey SK, and Das SK. Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse. Endocrinology 140: 5310-5321, 1999.
52. Van der Auwera I and D'Hooghe T. Superovulation of female mice delays embryonic and fetal development. Hum Reprod 16: 1237-1243, 2001.
53. Van der Auwera I, Pijnenborg R, and Koninckx P. The influence of in-vitro culture versus stimulated and untreated oviductal environment on mouse embryo development and implantation. Hum Reprod 14: 2570-2574, 1999.
54. Wahlsten D and Wainwright P. Applications of a morphological time scale to hereditary differences in prenatal mouse development. J Embryol Exp Morphol 42: 79-92, 1977.
55. Wilcox AJ, Baird DD, and Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 340: 1796-1769, 1999.
56. Yang Z, Chen D, Le S, and Harper JK. Differential hormonal regulation of leukemia inhibitory factor (LIF) in rabbit and mouse uterus. Mol Reprod Dev 43: 470-476, 1996.
57. Yang Z, Le S, Chen D, Cota J, Siero V, Yasukawa K, and Harper JK. Leukemia inhibitory factor, LIF receptor, and gp130 in the mouse uterus during early pregnancy. Mol Reprod Dev 42: 407-414, 1995.
58. Zheng M, Shi H, Segaloff DL, and Van Voorhis BJ. Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biol Reprod 64: 179-187, 2001.